Neptune Technologies & Bioressources Inc. Appoints Former Danone Canada CEO Thierry Houillion to Board of Directors
Tuesday, September 26 2006

Neptune Technologies & Bioressources Inc. Appoints Former Danone Canada CEO Thierry Houillion to Board of Directors

LAVAL, QC, Sept. 26 /CNW/ - Neptune Technologies & Bioressources Inc., (TSX.V: NTB), "Neptune" is pleased to announce it has appointed Mr. Thierry Houillion to the Board of Directors. This brings the number of Directors on Neptune's Board to six with five independent members. Neptune believes Mr. Houillion will complement and diversify the composition of the Board. "Mr. Houillion's knowledge, experience and vision will timely contribute to Neptune's penetration of the functional food industry. We are very excited to add him to the team," said Mr. Henri Harland, President & CEO of Neptune.

About Thierry Houillion:
Mr. Houillion brings over 22 years of food industry experience including three years as the CEO with Danone Waters of Canada, two years as the CEO of Danone Tunisia and seven years as the CEO of Danone Yogurt Canada during which time Danone was transformed from a regional producer to a national leader. During his tenure with Danone, Mr. Houillion attained an exceptional background in management processes, marketing, quality control and knowledge of the food industry.

Mr. Houillion holds a Scientific Baccalaureate from Belfort, France, a Degree from the International Commerce Academy in Paris, France and a Master's in Finance from Paris-Dauphine University.

In conjunction with the board appointment, Mr. Houillion will be granted 40,000 stock options at $3.00 for a 5-year term. The options will vest over 2 years. These securities have been allocated by Neptune to facilitate commitment, compensation, and alignment with shareholder interests.

About Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com
Neptune Technologies & Bioressources Inc. develops high value added nutritional products from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using an exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts.

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

Neither NASDAQ nor TSX venture exchange accepts responsibility for the adequacy or accuracy of this press release.
Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Toni Rinow, Ph.D., MBA
Corporate Development & Investor Relations
(450) 687-2262
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
# # #
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.
 

We communicate

NTB (TSX) CAN$ 1.93 +0.03
NEPT (NASDAQ) US$ 1.898 +0.068
 

press releases

Investor Relations Contact NEPTUNE TECHNOLOGIES & BIORESSOURCES